Clinical significance and prognostic value of urinary nucleosides in breast cancer patients

Clinical Biochemistry

Volumn 38, Issue 1, 2005, Pages 24-30

  Zheng, Yu Fang ^a   Kong, Hong Wei ^a   Xiong, Jian Hui ^a   Lv, Shen ^a,b   Xu, Guo Wang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MEKC; Principal component analysis; Urinary nucleosides

Indexed keywords

NUCLEOSIDE; TRANSFER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; URINALYSIS;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; MIDDLE AGED; NUCLEOSIDES; PROGNOSIS;

EID: 10644236443     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.09.021     Document Type: Article

References (28)

1. K. Itoh, T. Konno, T. Sasaki, S. Ishiwata, N. Ishida, and M. Misugaki Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma Clin. Chim. Acta 206 3 1992 181 189
2. J. Speer, C.W. Gehrke, K.C. Kwo, T.P. Waalkes, and E. Borek tRNA breakdown products as markers for cancer Cancer 44 1979 2120 2123
3. A. Fischbein, O.K. Sharma, I.J. Selikoff, and E. Borek Urinary excretion of modified nucleosides in patients with malignant mesothelioma Cancer Res. 43 1983 2971 2974
4. J. Thomale, and G. Nass Increasing urinary levels of modified nucleosides and bases during tumor development in mice Recent Results Cancer Res. 84 1983 377 378
5. E. Borek, and S.J. Kerr Atypical transfer RNA's and their origin in neoplastic cells Adv. Cancer Res. 15 1972 163 190
6. E. Borek, B.S. Baliga, and C.W. Gehrke High turnover rate of transfer RNA in tumor tissue Cancer Res. 37 1977 3362 3366
7. C.W. Gehrke, K.C. Kuo, T.P. Waalkes, and E. Borek Patterns of urinary excretion of modified nucleosides Cancer Res. 39 1979 1150 1153
8. C. Reynaud, C. Bruno, P. Boullanger, J. Grange, S. Barbesti, and A. Niveleau Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies Cancer Lett. 61 1991 255 262
9. A.J. Sasco, F. Rey, C. Reynaud, J.Y. Bobin, M. Clavel, and A. Niveleau Breast cancer prognostic significance of some modified urinary nucleosides Cancer Lett. 108 1996 157 162
10. B.S. Vold, L.E. Kraus, V.G. Rimer, and R.C. Coombes Use of a monoclonal antibody to detect elevated levels of a modified nucleoside. N-[9-β-d-Ribofuranosyl] purin-6-ylcarbamoyl]-l-threonine, in the urine of breast cancer patients Cancer Res. 46 1986 3164 3167
11. K. Nakano, T. Nakao, and K.H. Schram Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS Clin. Chim. Acta 218 1993 169 183
12. T. Rasmuson, and G.R. Bjork Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma Acta Oncol. 34 1995 61 67
13. G. Xu, C. Di Stefanoc, H.M. Liebich, Y. Zhang, and P. Lu Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients J. Chromatogr., B 732 1999 307 313
14. G.W. Xu, X. Lu, and Y.K. Zhang Two approaches to determining the urinary excretion patterns of nucleosides-HPLC and CE Chinese J. Chromatogr. 17 2 1999 97 101
15. G. Xu, and H.M. Liebich Normal and modified nucleosides in urine as potential tumor markers determined by MEKC and HPLC Clin. Lab. 20 2001 22 32
16. G.W. Xu, H.R. Schmid, X. Lu, H.M. Liebich, and P. Lu Excretion pattern investigation of Urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method Biomed. Chromatogr. 4 2000 1 5
17. H.M. Liebich, G. Xu, C. Di Stefanoc, and R. Lehmann Capillary electrophoresis of urinary normal and modified nucleosides of cancer patient J. Chromatogr., A 793 1998 341 347
18. R. Zhao, G. Xu, B. Yue, H.M. Liebich, and Y. Zhang Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors J. Chromatogr., A 828 1998 489 496
19. H.M. Liebich, R. Lehmann, G. Xu, H.G. Wahl, and H.U. Haring Application of capillary electrophoresis in clinical chemistry: clinical value of urinary modified nucleosides J. Chromatogr., B 745 2000 189 196
20. Y. Zheng, G. Xu, and D. Liu Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic chromatography Electrophoresis 23 2002 4104 4109
21. T. Rasmuson, G.R. Bjork, and L. Damber Tumor markers in mammary carcinoma an evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50 Acta Oncol. 26 1987 261 267
22. D.C. Tormey, T.P. Waalkes, and C.W. Gehrke Biological markers in breast carcinoma-Clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine J. Surg. Oncol. 14 1980 267 273
23. H.M. Liebich, C. Di Stefanoc, A. Wixforth, and H.R. Schmid Quantitation of urinary nucleosides by high-performance liquid chromatography J. Chromatogr., A 763 1997 193 197
24. H.M. Liebich, G.W. Xu, and C. Di Stefanoc Analysis of normal and modified nucleosides in urine by capillary electrophoresis Chromatographia 45 1997 396 401
25. Y. Zheng, Y. Zhang, and D. Liu Analysis of urinary nucleosides by micellar electrokinetic chromatography Chem. J. Chin. Univ. 22 6 2001 912 915
26. P. Pisani, D.M. Parkin, and J. Ferlay Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden Int. J. Cancer 55 1985 891 900
27. T.P. Waalkes, M.D. Abeloff, K.B. Woo, C.W. Gehrke, and E. Borek Biological markers and small cell carcinoma of the lung: a clinical evaluation of urinary ribonucleosides Cancer 50 1982 2457 2461
28. G. Sander, J. Hulsemann, and H. Topp Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites Ann. Nutr. Metab. 30 2 1986 137 141